Founded by industry veterans, BioBridges helps exceptional life sciences professionals pursue the work that inspires them. The company’s scalable Career Portfolio® Management model allows highly skilled professionals to focus on the work they are passionate about while collaborating with our clients to advance science and produce therapies for patients who need them.
Cindy Steinberg is a Founding Partner of BioBridges. She is a recognized industry thought leader and responsible for BioBridges’ successful integration of functional expertise into the community of professionals and programs that we serve. Cindy works to ensure that BioBridges continues to provide opportunity for career growth to its professionals and translates that increased expertise into a positive impact on client programs.
Cindy has more than 20 years of experience in the pharmaceutical and biotech industry. Some of her many successes include establishing a data management department at Millennium and leading her team to successfully process the data for Velcade, Millennium’s first approved product. Cindy also led data management for EMD Serono and Astra USA on the front lines of the pharmaceutical industry in management and as a researcher. She is an active member of the Drug Information Association (DIA), the Society for Clinical Data Management (SCDM), Women Entrepreneurs in Science and Technology (West), and Healthcare Business Women’s Association (HBA). She has served for eight years as co-chair for the Biostatistics/Data Management Committee for The Mass Biotech Council (MBC).
Jason Falchuk is a Founding Partner of BioBridges. Jason established the BioBridges’ Career Portfolio® Management model by building upon his experience representing and managing the careers of the industry’s most sought-after professionals. As the creative visionary behind BioBridges, Jason leads the company’s marketing efforts and works to provide a sense of community and to ensure a strong voice for our professionals who choose to define and thrive in their careers through the work that inspires them.
Jason has been actively involved in the professional services industry for over 20 years. Prior to co-founding BioBridges, some of his many experiences and accomplishments include developing a thriving life-sciences practice for a regional-based contract services company and establishing and leading a corporate university for Darwin Partners, which was responsible for developing and retaining hundreds of employees through the company’s high growth period, achieving revenues of 200 million. Jason began his career as an advocate for national freelance contractors. Jason served as the Chair of the New England Chapter of Clinical Research Professionals (NEAC-ACRP) Sponsorship Committee from 2006 – 2015.
Jeff Souza is the Chief Executive Officer and Partner of BioBridges. Jeff is an accomplished leader in the life sciences and healthcare-services industries. At BioBridges, he is responsible for the company’s overall leadership and continued growth. Jeff works to ensure that BioBridges’ actions are aligned with upholding a strong service culture for the community we serve.
Prior to joining BioBridges, Jeff served as a strategic advisor to BioBridges while CEO for Leaders for Today, a growing healthcare services organization. Prior to that, Jeff led the North American business unit for i3 Pharma, a United Healthcare Company. Jeff began his career as a medical laboratory scientist and nurse, eventually transitioning from practicing as a healthcare professional into the service industry at the Ritz Carlton, where he embraced and mastered his passion for service, which he uses as a driving force here at BioBridges. He is a nationally known speaker and writer on leadership, career management, and future trends in healthcare and the life sciences.
Warren Steinberg is the Chief Financial Officer at BioBridges. He is responsible for all financial areas including strategic planning, revenue enhancement, expansion analysis, projections, and daily oversight of financial operations. Warren ensures that the company has the sound financial foundation necessary to grow and serve the increasing number of professionals who have chosen to focus on the work that inspires them, and the growing number of client programs we serve.
Warren has more than 20 years of experience serving as a Chief Financial Officer, building and strengthening service companies for growth in the life sciences, technology, and software industries. He led exponential growth and tripled access to capital at Softworld, Inc., Medical Device Consulting, Inc., and Darwin Partners, Inc., among others. Warren is currently a member of the Financial Executive Networking Group, and Financial Executives International.
Susan Lincoln is the Director of Human Resources for BioBridges. She is dedicated to maintaining quality, up-to-date health and welfare benefits, and providing exemplary human resources support to our professionals, so that they can focus on the work that inspires them.
Susan has over 20 years of human resources experience, developing effective organizational policies that align strategic objectives with human resources initiatives. Prior to BioBridges, she managed compensation and benefits, training and development, installation of an HRIS system, and policy development at SalesLink. Susan managed the due diligence and integration issues associated with the acquisition of new corporate entities, as well as overseeing human resources issues associated with the opening of new facilities in the US and overseas. She is a member of the Society for Human Resource Management and the Northeast Human Resources Association.
Jenny Thayer is the Head of Medical Writing and Scientific Communications at BioBridges. She is responsible for providing flexible and scalable solutions that accomplish the work at hand in the areas of writing/communications, regulatory, and medical affairs. As a recognized industry thought leader, Jenny serves in an advisory capacity for both BioBridges’ professionals and clients. She works to fully understand clients’ programs while providing guidance and mentorship to professionals as she aligns them with programs where they can make an impact and continue to grow in their career. Jenny plays an active role in facilitating and contributing to the work while participating in key clinical development programs.
Jenny has more than 20 years of experience in the pharmaceutical and biotech industry. Some of her successes include having built five functions from the ground up, including medical writing, medical communications, and medical affairs. Jenny has led several cross-functional teams to achieve breakthrough performance, one of which completed the clinical content of a new marketing application in less than 5 weeks from phase 3 data tables to submission, resulting in the first acute treatment on the market in the US. Recently, she led a clinical team to produce the highly complex clinical content of a marketing application that was approved with no clinical questions from the agency. Her therapeutic experience spans ultra-rare to epidemic diseases. Jenny is a lifelong learner and loves education of all types—and is currently an instructor at Boston University teaching a course in medical writing for clinical research.
LeeAnn Ali is the Head of Clinical Development at BioBridges. She works with BioBridges’ clients to assist with strategic decision-making: providing on-demand clinical program management, gap-analyses, due diligence and clinical tech transfer, and resource optimization to facilitate the execution of clinical development programs to meet clinical, scientific, and business needs. In addition, LeeAnn works closely with BioBridges professionals to assess their skills and provide career guidance, allowing them to leverage their abilities and continue to grow by doing the work that inspires them.
LeeAnn has more than 20 years of experience successfully building and re-aligning clinical departments in start-up companies, large pharma, and CROs. Her extensive therapeutic expertise, from dermatology to oncology, devices, and biologies has made her an integral part of successful PMA and NDA submissions, including BIMO preparations. LeeAnn has held progressively responsible positions at Reprogenesis (currently Curis, Inc.), Averion, Inc. (currently ICON plc.), Johnson & Johnson, Dyax Corp, and IlluminOss Medical. She has served as a Co-Chair of the Clinical Trial Committee of the Massachusetts Biotechnology Council, and on executive committees for the Association of Clinical Research Professionals (ACRP). LeeAnn is currently an Advisory Board Member at Boston University School of Medicine and Metropolitan College.